Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
SG&A Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-49.6%
5Y CAGR+36.8%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-49.6%/yr
Annual compound
5Y CAGR
+36.8%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
4.8x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$183.29M-25.5%
2024$246.16M-36.1%
2023$385.02M-73.1%
2022$1.43B+65.7%
2021$862.95M+2152.8%
2020$38.31M+29.9%
2019$29.48M-